Exelixis (EXEL) Cash & Equivalents (2010 - 2026)

Exelixis' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $226.2 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 23.07% year-over-year to $226.2 million; the TTM figure through Apr 2026 stood at $226.2 million (up 23.07% YoY), while the FY2026 annual figure was $482.5 million, up 121.96% from the prior year.
• Cash & Equivalents was $226.2 million for Q2 2026 at Exelixis, down from $482.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $723.3 million in Q2 2022 to a low of $164.4 million in Q3 2025.
• Historically, Cash & Equivalents has averaged $385.8 million across 5 years, with a median of $376.3 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Cash & Equivalents sank 57.27% in 2024, then jumped 121.96% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $501.2 million in 2022, then tumbled by 47.53% to $263.0 million in 2023, then slipped by 1.77% to $258.3 million in 2024, then surged by 45.66% to $376.3 million in 2025, then tumbled by 39.9% to $226.2 million in 2026.
• The last three Cash & Equivalents figures came in at $226.2 million (Q2 2026), $482.5 million (Q1 2026), and $376.3 million (Q4 2025), per Business Quant data.